• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RUNX2 与 SCD1 相互作用并激活 Wnt/β-连环蛋白信号通路,促进肾透明细胞癌的进展。

RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.

机构信息

Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, P. R. China.

Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P. R. China.

出版信息

Cancer Med. 2023 Mar;12(5):5764-5780. doi: 10.1002/cam4.5326. Epub 2022 Oct 6.

DOI:10.1002/cam4.5326
PMID:36200301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10028032/
Abstract

BACKGROUND

Previous studies have demonstrated that Runt-associated transcription factor 2 (RUNX2) serves as the main transcription factor for osteoblast differentiation and chondrocyte maturation. RUNX2 is related to a variety of tumors, particularly tumor invasion and metastasis, while the expression and molecular mechanisms of RUNX2 in clear cell renal cell carcinoma (ccRCC) keep to be determined. Stearyl CoA desaturase 1 (SCD1), an endoplasmic reticulum fatty acid desaturase, transfers saturated fatty acids to monounsaturated fatty acids, is expressed highly in numerous malignancies.

METHODS

The Cancer Genome Atlas (TCGA) datebase and Western blot was used to analyzed the mRNA and protein levels of the target gene in ccRCC tissues and adjacent tissues. The proliferation ability of ccRCC cells was tested by colony forming and EdU assay. The migration ability of cells was detected by transwell assay. Immunoprecipitation was utilized to detect protein-protein interaction. Cycloheximide chase assay was used to measure the half-life of SCD1 protein.

RESULTS

In this study, the expressions of RUNX2 and SCD1 are increased in ccRCC tissues as well as ccRCC cell lines. Both RUNX2 and SCD1 could promote proliferation and migration in ccRCC cells. Furthermore, RUNX2 could physically interact with SCD1. In addition, the functional degradation and the inactivation of Wnt/β-catenin signaling pathway triggered by the downregulation of RUNX2 could be partly offset by the overexpression of SCD1.

CONCLUSION

The findings indicate that the RUNX2/SCD1 axis may act as a potential therapeutic target via the Wnt/β-catenin signaling pathway of ccRCC.

摘要

背景

先前的研究表明, runt 相关转录因子 2(RUNX2)是成骨细胞分化和软骨细胞成熟的主要转录因子。RUNX2 与多种肿瘤有关,尤其是肿瘤的侵袭和转移,而 RUNX2 在透明细胞肾细胞癌(ccRCC)中的表达和分子机制仍有待确定。硬脂酰辅酶 A 去饱和酶 1(SCD1),一种内质网脂肪酸去饱和酶,将饱和脂肪酸转移到单不饱和脂肪酸,在许多恶性肿瘤中表达水平较高。

方法

使用癌症基因组图谱(TCGA)数据库和 Western blot 分析 ccRCC 组织和相邻组织中靶基因的 mRNA 和蛋白水平。通过集落形成和 EdU 测定试验检测 ccRCC 细胞的增殖能力。通过 Transwell 测定试验检测细胞的迁移能力。利用免疫沉淀检测蛋白-蛋白相互作用。利用环己酰亚胺追踪试验测量 SCD1 蛋白的半衰期。

结果

在本研究中,RUNX2 和 SCD1 的表达在 ccRCC 组织和 ccRCC 细胞系中均增加。RUNX2 和 SCD1 均可促进 ccRCC 细胞的增殖和迁移。此外,RUNX2 可与 SCD1 发生物理相互作用。此外,下调 RUNX2 触发的 Wnt/β-catenin 信号通路的功能降解和失活可以部分被 SCD1 的过表达所抵消。

结论

这些发现表明,RUNX2/SCD1 轴可能通过 ccRCC 的 Wnt/β-catenin 信号通路作为潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/8d5dd20ab73e/CAM4-12-5764-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/e79e7ed15209/CAM4-12-5764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/00774bcc4069/CAM4-12-5764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/e51161daee20/CAM4-12-5764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/649085988c62/CAM4-12-5764-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/9fac622d6788/CAM4-12-5764-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/596dc05d5ba5/CAM4-12-5764-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/8581f2c3e520/CAM4-12-5764-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/8d5dd20ab73e/CAM4-12-5764-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/e79e7ed15209/CAM4-12-5764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/00774bcc4069/CAM4-12-5764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/e51161daee20/CAM4-12-5764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/649085988c62/CAM4-12-5764-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/9fac622d6788/CAM4-12-5764-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/596dc05d5ba5/CAM4-12-5764-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/8581f2c3e520/CAM4-12-5764-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a002/10028032/8d5dd20ab73e/CAM4-12-5764-g008.jpg

相似文献

1
RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.RUNX2 与 SCD1 相互作用并激活 Wnt/β-连环蛋白信号通路,促进肾透明细胞癌的进展。
Cancer Med. 2023 Mar;12(5):5764-5780. doi: 10.1002/cam4.5326. Epub 2022 Oct 6.
2
Phosphorylated MAPK11 promotes the progression of clear cell renal cell carcinoma by maintaining RUNX2 protein abundance.磷酸化 MAPK11 通过维持 RUNX2 蛋白丰度促进透明细胞肾细胞癌的进展。
J Cell Mol Med. 2023 Sep;27(17):2583-2593. doi: 10.1111/jcmm.17870. Epub 2023 Jul 31.
3
Positive feedback loop and synergistic effects between hypoxia-inducible factor-2α and stearoyl-CoA desaturase-1 promote tumorigenesis in clear cell renal cell carcinoma.缺氧诱导因子-2α与硬脂酰辅酶 A 去饱和酶-1之间的正反馈环和协同作用促进肾透明细胞癌的发生。
Cancer Sci. 2013 Apr;104(4):416-22. doi: 10.1111/cas.12108. Epub 2013 Mar 3.
4
Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.硬脂酰辅酶 A 去饱和酶 1 是透明细胞肾细胞癌的一个新的分子治疗靶点。
Clin Cancer Res. 2013 May 1;19(9):2368-80. doi: 10.1158/1078-0432.CCR-12-3249. Epub 2013 Apr 30.
5
High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.硬脂酰辅酶A去饱和酶1的高表达预示着透明细胞肾细胞癌患者的预后不良。
PLoS One. 2016 Nov 18;11(11):e0166231. doi: 10.1371/journal.pone.0166231. eCollection 2016.
6
Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.长链非编码RNA CCAT2通过调控肾透明细胞癌中的Wnt/β-连环蛋白信号通路促进细胞增殖和侵袭。
Tumour Biol. 2017 Jul;39(7):1010428317711314. doi: 10.1177/1010428317711314.
7
A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma.一个 Zic2/Runx2/NOLC1 信号轴介导了透明细胞肾细胞癌的肿瘤生长和转移。
Cell Death Dis. 2021 Mar 25;12(4):319. doi: 10.1038/s41419-021-03617-8.
8
Upregulation of SDHA inhibited proliferation, migration, and invasion of clear cell renal cell carcinoma cells via inactivation of the Wnt/β-catenin pathway.SDHA的上调通过Wnt/β-连环蛋白信号通路的失活抑制透明细胞肾癌细胞的增殖、迁移和侵袭。
J Recept Signal Transduct Res. 2022 Apr;42(2):180-188. doi: 10.1080/10799893.2021.1883060. Epub 2021 Feb 18.
9
TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.TRIM33 过表达抑制体内外肾透明细胞癌的进展。
Biomed Res Int. 2020 Aug 25;2020:8409239. doi: 10.1155/2020/8409239. eCollection 2020.
10
Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.通过 β-连环蛋白-RUNX2 轴鉴定 Moesin(MSN)作为结直肠癌的潜在治疗靶点。
Int J Mol Sci. 2023 Jun 30;24(13):10951. doi: 10.3390/ijms241310951.

引用本文的文献

1
Targeting Stearoyl-CoA Desaturase 1 Through PI3K-AKT-mTOR Signaling in Head and Neck Squamous Cell Carcinoma.通过PI3K-AKT-mTOR信号通路靶向硬脂酰辅酶A去饱和酶1在头颈部鳞状细胞癌中的作用
OTO Open. 2025 Jun 19;9(2):e70143. doi: 10.1002/oto2.70143. eCollection 2025 Apr-Jun.
2
Targeting fibroblasts in pathological bone formation: mechanisms and treatments.针对病理性骨形成中的成纤维细胞:机制与治疗方法
Front Cell Dev Biol. 2025 May 26;13:1612950. doi: 10.3389/fcell.2025.1612950. eCollection 2025.
3
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities.

本文引用的文献

1
RNA mA reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/β-catenin signaling.RNA mA 读码器 YTHDF2 通过靶向 AXIN1/Wnt/β-catenin 信号通路促进肺腺癌细胞的增殖和转移。
Cell Death Dis. 2021 May 13;12(5):479. doi: 10.1038/s41419-021-03763-z.
2
A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma.一个 Zic2/Runx2/NOLC1 信号轴介导了透明细胞肾细胞癌的肿瘤生长和转移。
Cell Death Dis. 2021 Mar 25;12(4):319. doi: 10.1038/s41419-021-03617-8.
3
lncRNA SNHG11 Promotes Gastric Cancer Progression by Activating the Wnt/β-Catenin Pathway and Oncogenic Autophagy.
肾细胞癌骨转移领域的新参与者及治疗机遇。
Int J Cancer. 2025 Feb 1;156(3):475-487. doi: 10.1002/ijc.35181. Epub 2024 Sep 22.
4
METTL14 Suppresses Tumor Stemness and Metastasis of Colon Cancer Cells by Modulating m6A-Modified SCD1.METTL14 通过调控 m6A 修饰的 SCD1 抑制结肠癌细胞的肿瘤干性和转移。
Mol Biotechnol. 2024 Aug;66(8):2095-2105. doi: 10.1007/s12033-023-00843-7. Epub 2023 Aug 17.
5
RUNX2 and Cancer.RUNX2 与癌症。
Int J Mol Sci. 2023 Apr 10;24(8):7001. doi: 10.3390/ijms24087001.
6
Role of RUNX2 in breast cancer development and drug resistance (Review).RUNX2在乳腺癌发展和耐药性中的作用(综述)
Oncol Lett. 2023 Mar 15;25(5):176. doi: 10.3892/ol.2023.13762. eCollection 2023 May.
lncRNA SNHG11 通过激活 Wnt/β-连环蛋白通路和致癌性自噬促进胃癌进展。
Mol Ther. 2021 Mar 3;29(3):1258-1278. doi: 10.1016/j.ymthe.2020.10.011. Epub 2020 Oct 15.
4
RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome.RUNX1 是与临床结果相关的肾细胞癌的驱动基因。
Cancer Res. 2020 Jun 1;80(11):2325-2339. doi: 10.1158/0008-5472.CAN-19-3870. Epub 2020 Mar 10.
5
Transcription factor RUNX2 regulates epithelial‑mesenchymal transition and progression in renal cell carcinomas.转录因子 RUNX2 调控肾细胞癌中的上皮-间充质转化和进展。
Oncol Rep. 2020 Feb;43(2):609-616. doi: 10.3892/or.2019.7428. Epub 2019 Dec 12.
6
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer.硬脂酰辅酶A去饱和酶1作为癌症治疗的靶点
Cancers (Basel). 2019 Jul 5;11(7):948. doi: 10.3390/cancers11070948.
7
Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death.硬脂酰辅酶 A 去饱和酶 1 可保护卵巢癌细胞免于铁死亡。
Cancer Res. 2019 Oct 15;79(20):5355-5366. doi: 10.1158/0008-5472.CAN-19-0369. Epub 2019 Jul 3.
8
Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2.Runx2 对成骨细胞增殖、分化和功能的调节。
Int J Mol Sci. 2019 Apr 4;20(7):1694. doi: 10.3390/ijms20071694.
9
CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.CDX2 通过反式激活 GSK-3β 和 Axin2 的表达抑制 Wnt/β-catenin 信号通路,从而抑制结肠癌细胞的增殖和肿瘤形成。
Cell Death Dis. 2019 Jan 10;10(1):26. doi: 10.1038/s41419-018-1263-9.
10
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.